John K. Scott Jr. - 29 Jun 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director, 10%+ Owner
Signature
/s/ Joseph W. Meyer for John K. Scott, Jr. by power of attorney
Issuer symbol
N/A
Transactions as of
29 Jun 2023
Net transactions value
+$1,073,600
Form type
4
Filing time
30 Jun 2023, 10:46:07 UTC
Previous filing
15 Jun 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $1,073,600 +12,200,000 +62% $0.0880 31,755,832 29 Jun 2023 Direct F1
holding NAVB Common Stock 10,139 29 Jun 2023 By spouse and children F2
holding NAVB Series G Redeemable Preferred Stock 2,270 29 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Navidea entered into a Letter Agreement with the Reporting Person, pursuant to which the Company agreed to repay $1,073,600 principal amount of an outstanding Term Note by issuing to the Reporting Person 12,200,000 shares of Common Stock, based on the closing stock price of $0.088 per share on June 28, 2023.
F2 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.